The increased levels of phospho-PKCδ, phospho-ERK, and EGR-1 expression in the lungs of COPD mice were suppressed by administering 25 mg/kg of verproside (Figure 6B). Here, PRKCD is linked to chronic obstructive pulmonary disease.